A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke

NCT06299033 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Ischemic Stroke

Interventions

DRUG: hNPC01

Sponsor

Hopstem Biotechnology Inc.